Early Life Intervention in Pediatrics Supported by E-health - SMOKE
Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and…
Conditions studied
Smoking Reduction, Asthma in Children, Wheezing, Non-Communicable Disease, Life Style, Behavior, Smoking
About this study
Unrestricted parental smoking habits are lifestyle risk behaviors associated with chronic, systemic inflammation, which promotes the pathogenesis of non-communicable diseases (NCDs). Exposure to secondhand tobacco smoke in early life contributes to the development of specific NCDs in children, i.e. asthma. Early preventive measures to improve lifestyle behavior in parents are therefore of utmost importance. The aim of ELIPSE-II is to assess whether an eHealth application intervention for parents is feasible and efficacious in lowering levels of urinary cotinine as a measure of second-hand smoke exposure in their children .
Interventions
- Behavioral: Life-Style app — The modules of the Life-Style app are introduced and unlocked sequentially during the first weeks of the intervention phase. Afterwards the modules are fully available. Duration and frequency of app-use is not limited. The parents are accompanied by a coach through the app, who gives regular structured feedback and individual inputs. The coach has access to all data collected in the app.
- Other: Sham Comparator — The parents get a flyer with information on second-hand smoke exposure and references to smoking cessation programs, and do not have an active app during the main intervention period.
Primary outcomes
- Change from baseline in urinary levels of cotinine in children (At 22 weeks after baseline (Post intervention))
- Change from baseline in urinary levels of cotinine in children (At 48 weeks after baseline (Follow-Up))
Eligibility information
Study locations
- Department of Paediatrics, Inselspital, Bern University Hospital, Bern, 3010 Switzerland
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.